Current advances in systems and integrative biology
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Systems biology has gained a tremendous amount of interest in the last few years. This is partly due to the realization that traditional approaches focusing only on a few molecules at a time cannot describe the impact of aberrant or modulated molecular environments across a whole system. Furthermore, a hypothesis-driven study aims to prove or disprove its postulations, whereas a hypothesis-free systems approach can yield an unbiased and novel testable hypothesis as an end-result. This latter approach foregoes assumptions which predict how a biological system should react to an altered microenvironment within a cellular context, across a tissue or impacting on distant organs. Additionally, re-use of existing data by systematic data mining and re-stratification, one of the cornerstones of integrative systems biology, is also gaining attention. While tremendous efforts using a systems methodology have already yielded excellent results, it is apparent that a lack of suitable analytic tools and purpose-built databases poses a major bottleneck in applying a systematic workflow. This review addresses the current approaches used in systems analysis and obstacles often encountered in large-scale data analysis and integration which tend to go unnoticed, but have a direct impact on the final outcome of a systems approach. Its wide applicability, ranging from basic research, disease descriptors, pharmacological studies, to personalized medicine, makes this emerging approach well suited to address biological and medical questions where conventional methods are not ideal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034 · cited 1×
“instead reflects the perturbations of the complex intracellular and intercellular network that links tissue and organ systems [88].”
BackgroundDNA methylation: roles in mammalian development
Smith, Z. D., & Meissner, A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3354 · Cited by 3,045 · cited 1×
“These epigenetic changes can act in concert [4] and they contribute to changes in levels of gene expression [5] and can direct which parts of the genetic code form a resultingmature transcript via alternative promoter selection and alternative splicing [6,7].”
BackgroundIntegration of biological networks and gene expression data using Cytoscape
Cline, M. S., Smoot, M., Cerami, E., Kuchinsky, A., Landys, N., Workman, C., Christmas, R., Avila-Campilo, I., Creech, M., Gross, B., et al. (2007) · Nature Protocols · doi:10.1038/nprot.2007.324 · Cited by 2,507
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042
The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
Vizcaíno, J. A., Côté, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1262 · Cited by 1,918
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · cited 4×
“The most relevant genetic determinants of AD are mutations in the amyloid precursor protein (APP), presenilin (PS)-1 and PS-2 known for triggering early-onset (b60 years) autosomal dominant AD [93].”
BackgroundInfluentialIntegrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · cited 1×
“An example of this type of approach was the identification of molecular interactions that are disrupted in patients with late AD onset, where the authors [115] built co-expression networks based on gene expression and genotyping data from postmortem brain tissues of hundreds of patients and healthy individuals.”
BackgroundKnopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey–Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001) · Neurology · doi:10.1212/wnl.56.9.1143 · Cited by 1,410
Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
Escott-Price, V., Bellenguez, C., Wang, L.-S., Choi, S.-H., Harold, D., Jones, L., Holmans, P., Gerrish, A., Vedernikov, A., Richards, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094661 · Cited by 1,398
COBRApy: COnstraints-Based Reconstruction and Analysis for Python
Ebrahim, A., Lerman, J. A., Palsson, B. O., & Hyduke, D. R. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-74 · Cited by 1,378 · cited 1×
“One popular toolbox for implementing constraintbased models is COBRA, developed on MatLab but also available as a package for Python [80].”
MethodA Whole-Cell Computational Model Predicts Phenotype from Genotype
Karr, J. R., Sanghvi, J. C., Macklin, D. N., Gutschow, M. V., Jacobs, J. M., Bolival, B., Assad-Garcia, N., Glass, J. I., & Covert, M. W. (2012) · Cell · doi:10.1016/j.cell.2012.05.044 · Cited by 1,300
Pathway Commons, a web resource for biological pathway data
Cerami, E. G., Gross, B. E., Demir, E., Rodchenkov, I., Babur, O., Anwar, N., Schultz, N., Bader, G. D., & Sander, C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1039 · Cited by 1,101 · cited 4×
“Cytoscape has a “pathway database” ‘app category’ containing pluginswhich derive data from a variety of information sources and provide some appropriate tools for pathway editing and enrichment analysis: CyKEGGParser manipulates KEGG files [72]; ReactomeFIPlugIn facilitates pathway enrichment analysis based on the Rea…”
MethodInfluentialChromatin organization marks exon-intron structure
Schwartz, S., Meshorer, E., & Ast, G. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1659 · Cited by 638 · cited 1×
“These epigenetic changes can act in concert [4] and they contribute to changes in levels of gene expression [5] and can direct which parts of the genetic code form a resultingmature transcript via alternative promoter selection and alternative splicing [6,7].”
BackgroundSystems genetics approaches to understand complex traits
Civelek, M., & Lusis, A. J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3575 · Cited by 621
Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study
Driver, J. A., Beiser, A., Au, R., Kreger, B. E., Splansky, G. L., Kurth, T., Kiel, D. P., Lu, K. P., Seshadri, S., & Wolf, P. A. (2012) · BMJ · doi:10.1136/bmj.e1442 · Cited by 425 · cited 1×
“They identified the TP53INP1 (chromosome 8), that curiously encodes a pro-apoptotic tumor suppressor, given the fact that epidemiological data exists supporting an inverse association between AD and cancer [100,101].”
BackgroundKim, T., Vidal, G. S., Djurisic, M., William, C. M., Birnbaum, M. E., Garcia, K. C., Hyman, B. T., & Shatz, C. J. (2013) · Science · doi:10.1126/science.1242077 · Cited by 410 · cited 5×
“[108] identified that the leukocyte immunoglobulin-like receptor 2 (LilrB2) act as a receptor for the Aβ in human brain, and their binding promotes the activation of cofilin, resulting in actin filament disassembly and spine loss, which could contribute to synaptic loss and cognitive impairment”
BackgroundInfluentialPrabakaran, S., Lippens, G., Steen, H., & Gunawardena, J. (2012) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1185 · Cited by 335 · cited 1×
“protein product [12], so that along with splice variants and alternative start sites, one multi-exon gene has the potential to form of a vast array of proteins.”
BackgroundGenes and pathways underlying regional and cell type changes in Alzheimer’s disease
Miller, J. A., Woltjer, R. L., Goodenbour, J. M., Horvath, S., & Geschwind, D. H. (2013) · Genome Medicine · doi:10.1186/gm452 · Cited by 275
MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
Kiko, T., Nakagawa, K., Tsuduki, T., Furukawa, K., Arai, H., & Miyazawa, T. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-130932 · Cited by 256
Harbig, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni027 · Cited by 141 · cited 1×
“It is also advantageous to either check for the latest version of annotation or create novel annotation using public resources [24].”
Background
Cited by
The pathobiome in animal and plant diseases.
Bass, D., Stentiford, G. D., Wang, H.-C., Koskella, B., & Tyler, C. R. (2019) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2019.07.012 · Cited by 376
Krishnan, M. L., Wang, Z., Silver, M., Boardman, J. P., Ball, G., Counsell, S. J., Walley, A. J., Montana, G., & Edwards, A. D. (2016) · Brain and Behavior · doi:10.1002/brb3.434 · Cited by 28
Welch, N., Singh, S. S., Kumar, A., Dhruba, S. R., Mishra, S., Sekar, J., Bellar, A., Attaway, A. H., Chelluboyina, A., Willard, B. B., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101023 · Cited by 17
Metadata
- Authors
- Robinson, S. W., Fernandes, M., & Husi, H.
- Venue
- Computational and Structural Biotechnology Journal
- Published
- 2014-08
- Volume
- 11
- Issue
- 18
- Pages
- 35-46
- ISSN
- 2001-0370 (ISSN-L)
- OpenAlex
- W2136994168
- Cited by
- 39
- References
- 20
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.